Shujie Wang, Ph.D. - Publications

Affiliations: 
2002 Virginia Commonwealth University, Richmond, VA, United States 
Area:
Pharmacology, Biochemistry

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Wang S, Lyu C, Duan G, Meng F, Yang Y, Yu Y, He X, Wang Z, Gottschalk M, Li G, Cai X, Wang G. Serotype 2 Infection Causes Host Immunomodulation Through Induction of Thymic Atrophy. Infection and Immunity. PMID 31932328 DOI: 10.1128/IAI.00950-19  0.48
2019 Wang S, Jia J, Liu D, Wang M, Wang Z, Li X, Wang H, Rui Y, Liu Z, Guo W, Nie J, Dai H. Matrix Metalloproteinase Expressions Play Important role in Prediction of Ovarian Cancer Outcome. Scientific Reports. 9: 11677. PMID 31406154 DOI: 10.1038/s41598-019-47871-5  0.48
2018 Hou X, Wang Z, Sun J, Li M, Wang S, Chen K, Gao Z. A microwave-assisted aqueous ionic liquid pretreatment to enhance enzymatic hydrolysis of Eucalyptus and its mechanism. Bioresource Technology. 272: 99-104. PMID 30316197 DOI: 10.1016/j.biortech.2018.10.003  0.48
2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Wang S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356  0.64
2015 Sperlazza J, Rahmani M, Beckta J, Aust M, Hawkins E, Wang SZ, Zhu SZ, Podder S, Dumur C, Archer K, Grant S, Ginder GD. Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation. Blood. PMID 26265695 DOI: 10.1182/blood-2015-03-631606  0.64
2014 Gu D, Wang S, Kuiatse I, Wang H, He J, Dai Y, Jones RJ, Bjorklund CC, Yang J, Grant S, Orlowski RZ. Inhibition of the MDM2 E3 Ligase induces apoptosis and autophagy in wild-type and mutant p53 models of multiple myeloma, and acts synergistically with ABT-737. Plos One. 9: e103015. PMID 25181509 DOI: 10.1371/journal.pone.0103015  0.64
2012 Yang Y, Li W, Qi H, Zhang Q, Chen J, Wang Y, Wang B, Wang S, Yu C. Detection of silver(I) ions based on the controlled self-assembly of a perylene fluorescence probe. Analytical Biochemistry. 430: 48-52. PMID 22864232 DOI: 10.1016/j.ab.2012.07.024  0.44
2012 Wang S, Yang R, Zou P, Hou M, Wu D, Shen Z, Lu X, Li Y, Chen X, Niu T, Sun H, Yu L, Wang Z, Zhang Y, Chang N, et al. A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia. International Journal of Hematology. 96: 222-8. PMID 22753022 DOI: 10.1007/s12185-012-1124-8  0.48
2003 Wang S, Hasham MG, Isordia-Salas I, Tsygankov AY, Colman RW, Guo YL. Upregulation of Cdc2 and cyclin A during apoptosis of endothelial cells induced by cleaved high-molecular-weight kininogen. American Journal of Physiology. Heart and Circulatory Physiology. 284: H1917-23. PMID 12742823 DOI: 10.1152/ajpheart.00861.2002  0.64
2003 Wang S, Wang Z, Dent P, Grant S. Induction of tumor necrosis factor by bryostatin 1 is involved in synergistic interactions with paclitaxel in human myeloid leukemia cells. Blood. 101: 3648-57. PMID 12522001 DOI: 10.1182/blood-2002-09-2739  0.64
2003 Wang S, Wang Z, Grant S. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms. Molecular Pharmacology. 63: 232-42. PMID 12488556  0.64
2002 Decker RH, Wang S, Dai Y, Dent P, Grant S. Loss of the Bcl-2 phosphorylation loop domain is required to protect human myeloid leukemia cells from flavopiridol-mediated mitochondrial damage and apoptosis. Cancer Biology & Therapy. 1: 136-44. PMID 12170773  0.64
2002 Wang Z, Wang S, Dai Y, Grant S. Bryostatin 1 increases 1-beta-D-arabinofuranosylcytosine-induced cytochrome c release and apoptosis in human leukemia cells ectopically expressing Bcl-x(L). The Journal of Pharmacology and Experimental Therapeutics. 301: 568-77. PMID 11961058  0.64
2001 Yu C, Wang S, Dent P, Grant S. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway. Molecular Pharmacology. 60: 143-54. PMID 11408609  0.64
2000 Wang Z, Wang S, Fisher PB, Dent P, Grant S. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21CIP1 in leukemic cell (U937) differentiation induced by low concentrations of 1-beta-D-arabinofuranosylcytosine. Differentiation; Research in Biological Diversity. 66: 1-13. PMID 10997587 DOI: 10.1046/j.1432-0436.2000.066001001.x  0.64
1999 Wang S, Wang Z, Boise LH, Dent P, Grant S. Bryostatin 1 enhances paclitaxel-induced mitochondrial dysfunction and apoptosis in human leukemia cells (U937) ectopically expressing Bcl-xL. Leukemia. 13: 1564-73. PMID 10516758  0.64
1999 Wang S, Wang Z, Boise L, Dent P, Grant S. Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis. Biochemical and Biophysical Research Communications. 259: 67-72. PMID 10334917 DOI: 10.1006/bbrc.1999.0669  0.64
1998 Wang S, Guo CY, Castillo A, Dent P, Grant S. Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937). Biochemical Pharmacology. 56: 635-44. PMID 9783732  0.64
1998 Wang Z, Su ZZ, Fisher PB, Wang S, VanTuyle G, Grant S. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells. Experimental Cell Research. 244: 105-16. PMID 9770354 DOI: 10.1006/excr.1998.4191  0.64
1997 Wang S, Vrana JA, Bartimole TM, Freemerman AJ, Jarvis WD, Kramer LB, Krystal G, Dent P, Grant S. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2. Molecular Pharmacology. 52: 1000-9. PMID 9396780  0.64
Show low-probability matches.